한글목차

수의 종양학 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 4억 5,000만 달러에서 2026년에는 5억 달러로, CAGR 11.0%로 성장할 것으로 예상됩니다. 지난 수년간의 성장에는 반려동물의 암 발생률 증가, 수의 종양학 서비스에 대한 인식 개선, 수술 및 방사선 장비의 기술 발전, 동물병원 및 전문 클리닉의 확대, 기존 화학요법 치료의 도입 등이 주요 요인으로 꼽힙니다.

수의 종양학 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 CAGR 11.3%로 7억 7,000만 달러에 달할 전망입니다. 예측 기간 동안의 성장 요인으로는 맞춤형 및 표적치료에 대한 수요 증가, 첨단 방사선 및 영상 진단 기술의 보급 확대, 면역요법 및 지지요법 이용 증가, 최소침습수술 기술 개발, 병용화학요법과 표적치료 프로토콜의 통합 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 표적 치료 및 맞춤화된 수의학 암 치료의 확대, 최소침습 수술 기술의 성장, 첨단 방사선 및 영상 진단 기술의 채택 증가, 병용 화학요법 프로토콜의 개발, 치료 계획에서 면역요법과 지지요법의 통합 등이 있습니다.

반려동물의 암 발병률 증가는 향후 수의 종양학 시장의 성장을 크게 견인할 것으로 예상됩니다. 암은 통제할 수 없는 세포 증식이 특징이며, 체내 다른 부위로 전이될 수 있고, 반려동물에서는 종양이나 부종과 같은 신체적 증상으로 나타나는 경우가 많습니다. 수의 종양학은 동물의 암 진단과 치료에 초점을 맞추고, 전이 및 질병의 확산을 억제하는 것을 목표로 합니다. 따라서 반려동물의 암 발생이 증가함에 따라 수의 종양학 서비스에 대한 수요가 증가할 것으로 예상됩니다. 예를 들어, 미국의 암 연구 전문지 'Cancer Letter'에 따르면, 2024년에는 미국에서 약 600만 마리의 반려견이 암 진단을 받을 것으로 예상됩니다. 또한, 영국 수의사 단체인 영국소동물수의사회(BSAVA)의 2023년 11월 자료에 따르면, 개 약 4마리 중 1마리, 고양이 약 5마리 중 1마리가 일생 동안 암 진단을 받을 것으로 추정됩니다. 이처럼 반려동물의 암 발병률 증가가 수의 종양학 시장의 성장을 견인하고 있습니다.

수의 종양학 시장의 주요 기업들은 암세포의 돌연변이로 인해 발생하는 종양 특이적 항원인 신생항원 개발에 집중하고 있습니다. 신항원은 종양 특이적 돌연변이에 의해 생성되는 특이적인 단백질 조각으로, 건강한 조직에서 발견되는 정상 항원과는 다릅니다. 이 단백질은 종양의 DNA의 유전적 변화(돌연변이)로 인해 발생합니다. 예를 들어, 2024년 10월, 미국에 본사를 둔 한 생명공학 기업이 개 암 백신 임상시험을 시작했습니다. 신항원 연구는 암 백신 및 기타 면역치료제 개발에 핵심적인 역할을 하고 있으며, 정상세포에 미치는 영향을 최소화하면서 암세포에 대한 면역반응을 특이적으로 강화하는 것을 목표로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Veterinary oncology involves the specialized diagnosis and treatment of cancer in animals, aiming to integrate cancer therapies while maintaining the overall quality of life for the affected animals. This field focuses on providing cancer medicine and treatment services tailored to the unique needs of animals.

The primary types of therapies in veterinary oncology include surgery, radiology, chemotherapy, and other specialized treatments. Surgery involves procedures to either remove or repair affected body parts or to assess the presence of disease. A diverse range of animals, including equines, canines, felines, and other species, are involved in veterinary oncology. The field encompasses various cancer types such as lymphomas, mast cell cancer, mammary cancer, squamous cell cancer, among others, specific to different animal species.

Tariffs have influenced the veterinary oncology market by raising the cost of imported surgical instruments, radiology devices, chemotherapy drugs, and immunotherapy agents, affecting pricing and accessibility in veterinary hospitals and clinics. Segments such as surgery, radiology, and chemotherapy are most impacted, particularly in regions like North America and Europe reliant on imported oncology products. However, tariffs have also encouraged domestic manufacturing, promoted cost-effective alternatives, and stimulated innovation in local oncology solutions, benefiting regional players.

The veterinary oncology market research report is one of a series of new reports from The Business Research Company that provides veterinary oncology market statistics, including veterinary oncology industry global market size, regional shares, competitors with a veterinary oncology market share, detailed veterinary oncology market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary oncology industry. This veterinary oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary oncology market size has grown rapidly in recent years. It will grow from $0.45 billion in 2025 to $0.5 billion in 2026 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to rising incidence of cancer in companion animals, growing awareness of veterinary oncology services, technological advancements in surgical and radiology equipment, expansion of veterinary hospitals and specialty clinics, adoption of conventional chemotherapy treatments.

The veterinary oncology market size is expected to see rapid growth in the next few years. It will grow to $0.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing demand for personalized and targeted therapies, growth in advanced radiology and imaging adoption, rising use of immunotherapy and supportive care, development of minimally invasive surgical techniques, integration of combination chemotherapy and targeted therapy protocols. Major trends in the forecast period include expansion of targeted and personalized veterinary cancer therapies, growth in minimally invasive surgical techniques, increasing adoption of advanced radiology and imaging technologies, development of combination chemotherapy protocols, integration of immunotherapy and supportive care in treatment plans.

The rising prevalence of cancer in pets is anticipated to significantly drive the growth of the veterinary oncology market in the future. Cancer is a condition characterized by uncontrolled cell growth that can spread to other parts of the body, and in pets, it often presents as physical symptoms like tumors or swelling. Veterinary oncology focuses on diagnosing and treating cancer in animals, aiming to reduce metastasis and the spread of the disease. Consequently, an increase in pet cancer cases is expected to elevate the demand for veterinary oncology services. For instance, according to the Cancer Letter, a US-based publication dedicated to cancer research, an estimated 6 million pet dogs will be diagnosed with cancer in the United States in 2024. Additionally, data from the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary organization, indicated in November 2023 that approximately 1 in 4 dogs and 1 in 5 cats will be diagnosed with cancer during their lifetime. Thus, the increasing prevalence of cancer in pets is driving the veterinary oncology market forward.

Leading companies in the veterinary oncology market are concentrating on developing neoantigens, which are unique tumor-specific antigens resulting from mutations in cancer cells. Neoantigens are distinct protein fragments produced by tumor-specific mutations, differentiating them from normal antigens found in healthy tissues. These proteins arise from genetic alterations (mutations) in the tumor's DNA. For example, in October 2024, a US-based biotechnology company launched a cancer vaccine trial for dogs. The exploration of neoantigens is central to the development of cancer vaccines and other forms of immunotherapy, aiming to enhance the immune response specifically against cancer cells while minimizing the impact on normal cells.

In September 2024, Boehringer Ingelheim, a Germany-based pharmaceutical company, acquired Saiba Animal Health AG for an undisclosed amount. Through this acquisition, Boehringer Ingelheim aimed to strengthen its veterinary therapeutics pipeline by integrating Saiba's innovative technology platform for developing novel therapeutic medicines, including potential treatments for chronic diseases such as cancer in pets. Saiba Animal Health AG is a Switzerland-based developer of therapeutic vaccines and advanced technology platforms targeting chronic conditions in companion animals, with potential applications across oncology and related therapeutic areas.

Major companies operating in the veterinary oncology market are PetCure Oncology Inc., Zoetis Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Sante Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, ZENOAQ GmbH, Oncovet Clinical Research Inc.

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary oncology market includes revenues earned by entities by providing cryosurgery, comprehensive care, immunotherapy, and palliative care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Oncology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary oncology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Therapy: Surgery; Radiology; Chemotherapy; Other Therapies
• 2) By Animal Type: Equine; Canine; Feline; Other Animal Types
• 3) By Cancer Type: Lymphoma; Mast Cell Cancer; Mammary And Squamous Cell Cancer; Other Cancer Types
• Subsegments:
• 1) By Surgery: Tumor Resection; Palliative Surgery; Laparoscopic Surgery; Amputation
• 2) By Radiology: Radiation Therapy; Stereotactic Radiosurgery; Brachytherapy; Imaging Techniques
• 3) By Chemotherapy: Injectable Chemotherapy; Oral Chemotherapy; Combination Chemotherapy Protocols; Targeted Therapy Agents
• 4) By Other Therapies: Immunotherapy; Photodynamic Therapy; Supportive Care; Alternative Therapies
• Companies Mentioned: PetCure Oncology Inc.; Zoetis Inc.; Varian Medical Systems Inc.; Accuray Incorporated; Boehringer Ingelheim International GmbH; Elanco Animal Health Inc.; One Health Company Inc.; Regeneus Limited; VetDC Inc.; Pharmaust Limited; AdvaVet Inc.; Nippon Zenyaku Kogyo Company Limited; AB Science SAS; Pfizer Inc.; Jaguar Animal Health Solutions Inc.; Orion Corporation A/B; Virbac SA; SeQuent Scientific Limited; Ceva Sante Animale S.A.; Vetoquinol S.A.; IDVet Inc.; Bayer Aktiengesellschaft; ZENOAQ GmbH; Oncovet Clinical Research Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Veterinary Oncology Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Veterinary Oncology Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Veterinary Oncology Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Veterinary Oncology Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Expansion Of Targeted And Personalized Veterinary Cancer Therapies
  • 4.2.2 Growth In Minimally Invasive Surgical Techniques
  • 4.2.3 Increasing Adoption Of Advanced Radiology And Imaging Technologies
  • 4.2.4 Development Of Combination Chemotherapy Protocols
  • 4.2.5 Integration Of Immunotherapy And Supportive Care In Treatment Plans

5. Veterinary Oncology Market Analysis Of End Use Industries

• 5.1 Veterinary Hospitals
• 5.2 Veterinary Specialty Clinics
• 5.3 Research Institutes
• 5.4 Academic Veterinary Centers
• 5.5 Oncology Treatment Centers

6. Veterinary Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Oncology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Veterinary Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Veterinary Oncology Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Veterinary Oncology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Veterinary Oncology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Oncology Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Oncology Market Segmentation

• 9.1. Global Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Surgery, Radiology, Chemotherapy, Other Therapies
• 9.2. Global Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Equine, Canine, Feline, Other Animal Types
• 9.3. Global Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types
• 9.4. Global Veterinary Oncology Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation
• 9.5. Global Veterinary Oncology Market, Sub-Segmentation Of Radiology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques
• 9.6. Global Veterinary Oncology Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents
• 9.7. Global Veterinary Oncology Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

10. Veterinary Oncology Market Regional And Country Analysis

• 10.1. Global Veterinary Oncology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Veterinary Oncology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Oncology Market

• 11.1. Asia-Pacific Veterinary Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Oncology Market

• 12.1. China Veterinary Oncology Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Oncology Market

• 13.1. India Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Oncology Market

• 14.1. Japan Veterinary Oncology Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Oncology Market

• 15.1. Australia Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Oncology Market

• 16.1. Indonesia Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Oncology Market

• 17.1. South Korea Veterinary Oncology Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Oncology Market

• 18.1. Taiwan Veterinary Oncology Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Oncology Market

• 19.1. South East Asia Veterinary Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Oncology Market

• 20.1. Western Europe Veterinary Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Oncology Market

• 21.1. UK Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Oncology Market

• 22.1. Germany Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Oncology Market

• 23.1. France Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Oncology Market

• 24.1. Italy Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Oncology Market

• 25.1. Spain Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Oncology Market

• 26.1. Eastern Europe Veterinary Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Oncology Market

• 27.1. Russia Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Oncology Market

• 28.1. North America Veterinary Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Oncology Market

• 29.1. USA Veterinary Oncology Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Oncology Market

• 30.1. Canada Veterinary Oncology Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Oncology Market

• 31.1. South America Veterinary Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Oncology Market

• 32.1. Brazil Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Oncology Market

• 33.1. Middle East Veterinary Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Oncology Market

• 34.1. Africa Veterinary Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Veterinary Oncology Market, Segmentation By Therapy, Segmentation By Animal Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Oncology Market Regulatory and Investment Landscape

36. Veterinary Oncology Market Competitive Landscape And Company Profiles

• 36.1. Veterinary Oncology Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Veterinary Oncology Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Veterinary Oncology Market Company Profiles
  • 36.3.1. PetCure Oncology Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Accuray Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Oncology Market Other Major And Innovative Companies

• Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Sante Animale S.A., Vetoquinol S.A.

38. Global Veterinary Oncology Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Oncology Market

40. Veterinary Oncology Market High Potential Countries, Segments and Strategies

• 40.1 Veterinary Oncology Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Veterinary Oncology Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Veterinary Oncology Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer